FI
CDTX

Fosun International’s Cidara Therapeutics CDTX Stock Holding History

Fosun International’s Portfolio CDTX Stock Details CDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-15,334
Closed -$481K – 248
2019
Q2 		$481K Hold
15,334
– – 0.03% 221
2019
Q1 		$773K Hold
15,334
– – 0.05% 184
2018
Q4 		$659K Hold
15,334
– – 0.04% 185
2018
Q3 		$1.36M Buy
+15,334
New +$1.35M 0.07% 119

Other funds holding CDTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Fosun International's CDTX Position: Q3 2019 in Review

Fosun International sold out of Cidara Therapeutics (CDTX) in Q3 2019, closing a stake of 15,334 shares — an estimated $481K sold.

Fosun International first reported a position in CDTX in Q3 2018 and held it in 4 quarters. The position peaked at $1.36M in Q3 2018. 39 funds tracked by Wall St. Rank hold CDTX as of Q3 2019.

  • Fosun International reported no remaining Cidara Therapeutics position as of Q3 2019 after selling out during the quarter.
  • Fosun International sold 15,334 Cidara Therapeutics shares in Q3 2019, an estimated $481K.
  • Fosun International first reported a position in Cidara Therapeutics in Q3 2018 and held it in 4 quarters.
  • Fosun International's Cidara Therapeutics position peaked at $1.36M in Q3 2018.
  • 39 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q3 2019.

Based on Fosun International's 13F filing for Q3 2019, filed 12 Nov 2019.